Question 1

What are the potential side effects of JSKN016 and D-0502?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer clinical trial (NCT07336771). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer clinical trial (NCT07336771). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer clinical trial (NCT07336771). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I expect during the trial in terms of tests and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer clinical trial (NCT07336771). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks involved in participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer clinical trial (NCT07336771). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer clinical trial (NCT07336771). Contact the study team or your healthcare provider for specific answers.

What this study is about